Novozymes Biopharma and SAFC, a member of the Sigma-Aldrich Group, have extended by 10 years their joint agreement for LONG R3. SAFC will retain exclusive marketing and distribution rights to Novozymes’s LONG R³IGF-I (LONG R3) growth factor for industrial cell culture applications. The highly potent growth factor is manufactured specifically for customers in the cell culture market and according to the company, enables clients to reduce operational and regulatory complexity and minimize manufact...